Annual Accounts Payable
$18.60 K
+$7700.00+70.64%
December 31, 2023
Summary
- As of February 21, 2025, GDTC annual accounts payable is $18.60 thousand, with the most recent change of +$7700.00 (+70.64%) on December 31, 2023.
- During the last 3 years, GDTC annual accounts payable has risen by +$4300.00 (+30.07%).
- GDTC annual accounts payable is now -45.61% below its all-time high of $34.20 thousand, reached on December 31, 2021.
Performance
GDTC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$33.00 K
+$14.40 K+77.42%
June 30, 2024
Summary
- As of February 21, 2025, GDTC quarterly accounts payable is $33.00 thousand, with the most recent change of +$14.40 thousand (+77.42%) on June 30, 2024.
- Over the past year, GDTC quarterly accounts payable has stayed the same.
- GDTC quarterly accounts payable is now -35.04% below its all-time high of $50.80 thousand, reached on June 30, 2022.
Performance
GDTC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
GDTC Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.6% | 0.0% |
| 3 y3 years | +30.1% | 0.0% |
| 5 y5 years | +30.1% | 0.0% |
GDTC Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.6% | +70.6% | -35.0% | +202.8% |
| 5 y | 5-year | -45.6% | +70.6% | -35.0% | +202.8% |
| alltime | all time | -45.6% | +70.6% | -35.0% | +202.8% |
CytoMed Therapeutics Limited Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $33.00 K(+77.4%) |
| Dec 2023 | $18.60 K(+70.6%) | $18.60 K(-58.9%) |
| Jun 2023 | - | $45.30 K(+315.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $10.90 K(-68.1%) | $10.90 K(-78.5%) |
| Jun 2022 | - | $50.80 K(+48.5%) |
| Dec 2021 | $34.20 K(+139.2%) | $34.20 K |
| Dec 2020 | $14.30 K | - |
FAQ
- What is CytoMed Therapeutics Limited annual accounts payable?
- What is the all time high annual accounts payable for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual accounts payable year-on-year change?
- What is CytoMed Therapeutics Limited quarterly accounts payable?
- What is the all time high quarterly accounts payable for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited quarterly accounts payable year-on-year change?
What is CytoMed Therapeutics Limited annual accounts payable?
The current annual accounts payable of GDTC is $18.60 K
What is the all time high annual accounts payable for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual accounts payable is $34.20 K
What is CytoMed Therapeutics Limited annual accounts payable year-on-year change?
Over the past year, GDTC annual accounts payable has changed by +$7700.00 (+70.64%)
What is CytoMed Therapeutics Limited quarterly accounts payable?
The current quarterly accounts payable of GDTC is $33.00 K
What is the all time high quarterly accounts payable for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high quarterly accounts payable is $50.80 K
What is CytoMed Therapeutics Limited quarterly accounts payable year-on-year change?
Over the past year, GDTC quarterly accounts payable has changed by $0.00 (0.00%)